Press Releases

2-9-10: Trigemina Conducting Phase IIa Clinical Trial in Chronic Daily Headache

5-25-10: Trigemina, Inc. Reports Preliminary Results for Phase IIa Clinical Trial in Chronic Daily Headache

8-10-10: Trigemina, Inc. Reports Positive Results with its Lead Compound TI-001 in a Phase IIa Clinical Trial for Chronic Daily Headache